SCHEMBL8029115

SCHEMBL8029115

COc1ccc2[nH]cc(Br)c(=O)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 1/20 0.56
GPR84 Q9NQS5 2/20 0.55
NR4A2 P43354 1/20 0.54
LMNA P02545 4/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HTR2B P41595 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
KDM4E B2RXH2 3/20 0.52
HSD17B10 Q99714 2/20 0.52
HPGD P15428 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
MEN1 O00255 1/20 0.51
MITF O75030 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4475932 0.86 GPR84 (0.62) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL7262267 0.78 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL21158551 0.78 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL11097545 0.78 ALDH1A1 (0.80) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL18392172 0.77 PDE4B (0.59) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL5327318 0.77 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL2053494 0.77 HTT (0.70) ALDH1A1CYP1A2CYP2C19NR4A2LMNA
SCHEMBL18392182 0.77 PDE4B (0.52) ALDH1A1CYP1A2CYP2C19GPR84NR4A2
SCHEMBL6786495 0.77 KDM4E (0.50) ALDH1A1LMNASMN1; SMN2KDM4EHPGD
SCHEMBL7262282 0.76 ABCG2 (0.55) ALDH1A1CYP1A2CYP2C19GPR84NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166031-A Substituted tetralins, chromans and related compounds in the treatment of asthma PFIZER INC, (US) 2000-12-26 US disclosed
EP-0313295-B1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA, ARTHRITIS AND RELATED DISEASES PFIZER INC. (US) 1993-07-28 EP disclosed
WO-1989003681-A1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA PFIZER INC. (US) 1989-05-05 WO disclosed
EP-0313295-A2 Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1989-04-26 EP disclosed
EP-0313296-A2 Substituted chromans and related compounds in the treatment of asthma PFIZER INC. (US) 1989-04-26 EP disclosed